Esta página se tradujo automáticamente y no se garantiza la precisión de la traducción. por favor refiérase a versión inglesa para un texto fuente.

Accompanying ALZHEIMER CAREGIVER (ACCAIDANT)

26 de junio de 2019 actualizado por: University Hospital, Bordeaux

ALZHEIMER'S CAREGIVER Accompaniment

Initiatives have been taken hotline in France and abroad for other conditions, they provide support to patients and their caregivers.

Descripción general del estudio

Estado

Terminado

Intervención / Tratamiento

Descripción detallada

This is a descriptive pilot study, non-interventional, before / after, mono-centric, evaluative, prospective cohort with type score description. The tool used is the grid "mini Zarit", she evaluates the caregiver burden. This grid is enabled in the French version and commonly used in these pathologies.

The evaluation of the quality of life of the caregiver will be performed with the scale "EQ-5D". This tool is easy to use phone, it contains few items. Also there is very little evidence referring to the suffering or negative feelings. It therefore avoids inducing to helping unknown team consultation memory an emotionally negative discourse.

There is no validated tool measuring the service delivered to a nurse hotline. The investigators offer a nurse questionnaire 7 items grouping expectations for the first consultation memory (consultation period, diagnosis, course of the consultation, organization of monitoring). It also provides an update on the daily experiences of the caregiver relative to the organization of care and helped the organization of domestic life of helped.

Nursing questionnaire will assess whether the responses of the nurse in relation to questions about the memory request for consultation were understood in relation to the items. Also, if the caregiver is in support of application in everyday life, the questionnaire will determine if the nursing accompaniment allows the caregiver to acquire knowledge or skills, or better organization of everyday life. The question of the entourage of the caregiver assesses the isolation level of the caregiver and whether the environment is not mobilized or after an update with the nurse.

If help is hospitalized, the pattern will be recovered. The Scientific Council will assess whether the information collected and the information provided would have prevented it.

Tipo de estudio

De observación

Inscripción (Actual)

45

Contactos y Ubicaciones

Esta sección proporciona los datos de contacto de quienes realizan el estudio e información sobre dónde se lleva a cabo este estudio.

Ubicaciones de estudio

      • Pessac, Francia, 33600
        • CHU de Bordeaux

Criterios de participación

Los investigadores buscan personas que se ajusten a una determinada descripción, denominada criterio de elegibilidad. Algunos ejemplos de estos criterios son el estado de salud general de una persona o tratamientos previos.

Criterio de elegibilidad

Edades elegibles para estudiar

18 años y mayores (Adulto, Adulto Mayor)

Acepta Voluntarios Saludables

Géneros elegibles para el estudio

Todos

Método de muestreo

Muestra no probabilística

Población de estudio

Helping with age ≥ 18 years, speaking and understanding the French and available to accompany the patient to the consultation

Descripción

Inclusion Criteria:

  • Helping with age ≥ 18 years
  • Helping speak and understand the French
  • Help available to accompany the patient to the consultation
  • Helping calling for the first time the memory center
  • Helping who noticed a cognitive disorder in assisted
  • Age over 75 years
  • beneficiary or affiliated to a social security scheme Patient
  • Patient with a cognitive disorder noticed by the caregiver

Exclusion Criteria:

  • Helping placed under judicial protection
  • Any medical or paramedical personnel in connection with the care of a nursing home eligible patient (Accommodation Establishment for dependent elderly, hospital, SSR (Care and Rehabilitation Services), institutional caregivers,
  • private health professionals, such as neighborhood (doctor, nurse liberal, physiotherapist
  • Neighborhood.

Plan de estudios

Esta sección proporciona detalles del plan de estudio, incluido cómo está diseñado el estudio y qué mide el estudio.

¿Cómo está diseñado el estudio?

Detalles de diseño

Cohortes e Intervenciones

Grupo / Cohorte
Intervención / Tratamiento
ALZHEIMER CAREGIVER
Caregiver available to accompany the patient to the consultation, helping calling for the first time the memory center, aidant who noticed a cognitive disorder help, having a family link identified with the patient
The tool used is a nurse card: there is no validated tool on the expectations of the caregiver in his memory referral. This is a pragmatic and practical questionnaire memory consultation request and domestic life with few items, practical use by telephone.

¿Qué mide el estudio?

Medidas de resultado primarias

Medida de resultado
Medida Descripción
Periodo de tiempo
score of the grid "MiniZarit"
Periodo de tiempo: Month 1
The evaluation of the quality of life of the caregiver, score between 0 and 7. point for positive response for difficulties in family life, difficulties in relationships with friends, hobbies, or in your job, a repercussion on health (physical and / or psychological), feeling that caregiver is no longer recognizing his parent, he afraid for the future of his parent, he would like to be (more) helped to take care of his parent, he feel a burden in taking care of his parent.
Month 1
score of the EuroQuol scale
Periodo de tiempo: Month 1

The evaluation of the quality of life of the caregiver

The point repartition :

Mobility (1 point : to have no problem getting around on foot ; 2 : to have problems getting around on foot; 3. to oblige to remain in bed) Self-sufficiency (1 point : to have no problem taking care of myself; 2 : to have problems washing or dressing myself alone;3 : to be unable to wash or dress myself alone) Regular activities (1 point : to have no problem performing my daily activities (eg work, study, housework, family activities or hobbies) ;2. : to have problems to perform my day-to-day activities;3. : to be unable to perform my normal activities.) Pain / discomfort (1. : to have no pain or discomfort; 2. : to have moderate pain or discomfort (s), 3. : to have severe pain or discomfort (s)) Anxiety / Depression (1. : to be not anxious or depressed; 2. : to be moderately anxious or depressed ;3. : to be extremely anxious or depressed)

Month 1

Medidas de resultado secundarias

Medida de resultado
Medida Descripción
Periodo de tiempo
Number of days between pre-clinical consultation and consultation MEMORY
Periodo de tiempo: Month 3
Impact of pre-clinical consultation on information support in consultation MEMORY
Month 3
Questionnary for caregivers' organization
Periodo de tiempo: Day 1
Evalution of professional helpers, number of technical assistance (remote alarm ...), nature of handicap , presence of correction device, number of taking medication drugs, Sleep is good or not, recent weight evolution
Day 1
Questionnary for caregivers' organization
Periodo de tiempo: Month 1
Evalution of professional helpers, number of technical assistance (remote alarm ...), nature of handicap , presence of correction device, number of taking medication drugs, Sleep is good or not, recent weight evolution
Month 1

Colaboradores e Investigadores

Aquí es donde encontrará personas y organizaciones involucradas en este estudio.

Investigadores

  • Investigador principal: Isabelle GUILLARD, University of Bordeaux

Fechas de registro del estudio

Estas fechas rastrean el progreso del registro del estudio y los envíos de resultados resumidos a ClinicalTrials.gov. Los registros del estudio y los resultados informados son revisados ​​por la Biblioteca Nacional de Medicina (NLM) para asegurarse de que cumplan con los estándares de control de calidad específicos antes de publicarlos en el sitio web público.

Fechas importantes del estudio

Inicio del estudio (Actual)

12 de diciembre de 2018

Finalización primaria (Actual)

7 de junio de 2019

Finalización del estudio (Actual)

7 de junio de 2019

Fechas de registro del estudio

Enviado por primera vez

21 de mayo de 2019

Primero enviado que cumplió con los criterios de control de calidad

20 de junio de 2019

Publicado por primera vez (Actual)

21 de junio de 2019

Actualizaciones de registros de estudio

Última actualización publicada (Actual)

1 de julio de 2019

Última actualización enviada que cumplió con los criterios de control de calidad

26 de junio de 2019

Última verificación

1 de mayo de 2019

Más información

Términos relacionados con este estudio

Información sobre medicamentos y dispositivos, documentos del estudio

Estudia un producto farmacéutico regulado por la FDA de EE. UU.

No

Estudia un producto de dispositivo regulado por la FDA de EE. UU.

No

Esta información se obtuvo directamente del sitio web clinicaltrials.gov sin cambios. Si tiene alguna solicitud para cambiar, eliminar o actualizar los detalles de su estudio, comuníquese con register@clinicaltrials.gov. Tan pronto como se implemente un cambio en clinicaltrials.gov, también se actualizará automáticamente en nuestro sitio web. .

Ensayos clínicos sobre Enfermedad de Alzheimer

Ensayos clínicos sobre semi-structured interview

3
Suscribir